GlassScriptPhysician profile
Michael David Noble
NPI 1689090102
$6,491.79
in general payments reported to CMS, 2019-2025
17 companies · $756 in 2025
The $756 reported for 2025 was more than what 86% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $158 · 2020: $298 · 2021: $413 · 2022: $918 · 2023: $2,860 · 2024: $1,089 · 2025: $756.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,242 · Travel and Lodging: $1,242 · Entertainment: $220.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,242.38 |
| Travel and Lodging | $1,241.68 |
| Entertainment | $220.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $2,123.74 | 2019-2025 | Dailies Total1, Precision 1, Total30 |
| Biotissue Holdings INC. | $2,008.82 | 2022-2025 | |
| Coopervision INC. | $533.35 | 2022-2025 | Myday Contact Lens, Misight Contact Lens |
| Mallinckrodt Hospital Products INC. | $444.72 | 2021-2024 | Acthar |
| Glaukos Corporation | $281.40 | 2025 | Istent, Idosetr |
| Bausch & Lomb Americas INC. | $227.91 | 2023-2025 | Miebo, Xiidra |
| Optos, INC. | $220.20 | 2023-2024 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Tarsus Pharmaceuticals, INC. | $153.17 | 2025 | Xdemvy |
| Horizon Therapeutics Plc | $123.05 | 2023 | Tepezza |
| Allergan, INC. | $103.99 | 2022 | |
| Shire North American Group INC | $99.98 | 2019 | |
| Carl Zeiss Meditec Ag | $38.80 | 2020 | |
| Oyster Point Pharma, INC. | $36.77 | 2025 | Ryzumvi, Tyrvaya |
| Abbvie INC. | $35.90 | 2022-2024 | |
| Novartis Pharmaceuticals Corporation | $29.80 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Surgical Vision, INC. | $17.98 | 2023 | Lipiflow System Activator (Disposable) |
| Johnson & Johnson Vision Care, INC. | $12.21 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Noble listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.